Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Keros Therapeutics, Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2020-04-13
Purchase		2023-01-20
4:32 pm		Keros Therapeutics Inc.KROSKnowles Julius
Director		1,191$20.98$24,987575,492
(Indirect
Direct)		View
2022-07-15
Sale		2022-07-19
4:40 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		46,034$30$1,381,020103,855
(Direct)		View
2022-07-13
Sale		2022-07-15
4:40 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		1,916$30$57,480149,889
(Direct)		View
2022-05-11
Sale		2022-05-13
4:37 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$41.9$222,050151,805
(Direct)		View
2022-04-11
Sale		2022-04-13
4:36 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$62.77$332,705157,105
(Direct)		View
2022-04-06
Sale		2022-04-08
4:21 pm		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		1,728$65$112,3208,002
(Direct)		View
2022-04-04
Sale		2022-04-06
4:49 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		7,950$60$477,000162,405
(Direct)		View
2022-04-01
Sale		2022-04-05
4:31 pm		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		864$57.49$49,6759,730
(Direct)		View
2022-03-11
Sale		2022-03-15
4:37 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$53.38$141,449170,355
(Direct)		View
2022-02-11
Sale		2022-02-15
4:26 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$52.06$137,965173,005
(Direct)		View
2022-01-11
Sale		2022-01-13
4:39 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$53.75$142,447175,655
(Direct)		View
2022-01-05
Sale		2022-01-07
4:35 pm		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$60$159,000178,305
(Direct)		View
2022-01-03
Sale		2022-01-05
7:14 pm		Keros Therapeutics Inc.KROSKnowles Julius
Director		47,651$57.84$2,756,116232,727
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-05-01
Option Award		2023-05-03
4:45 pm		N/A
2033-04-30		Keros Therapeutics Inc.KROSSeth Alpna
Director		20,000$020,000
(Direct)		View
2023-04-08
Exercise		2023-04-11
4:05 pm		N/A
2029-06-18		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		4,000$0297,943
(Direct)		View
2023-04-08
Exercise		2023-04-11
4:05 pm		N/A
N/A		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		4,000$0.48297,943
(Direct)		View
2023-02-16
Option Award		2023-02-17
4:19 pm		N/A
2033-02-15		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		100,000$0100,000
(Direct)		View
2023-02-16
Option Award		2023-02-17
4:15 pm		N/A
2033-02-15		Keros Therapeutics Inc.KROSCooper Simon Peter
Chief Medical Officer		40,000$040,000
(Direct)		View
2023-02-16
Option Award		2023-02-17
4:14 pm		N/A
2033-02-15		Keros Therapeutics Inc.KROSRegnante Keith
Chief Financial Officer		40,000$040,000
(Direct)		View
2023-02-16
Option Award		2023-02-17
4:13 pm		N/A
2033-02-15		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		200,000$0200,000
(Direct)		View
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$0.00011,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$01,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:40 pm		N/A
N/A		Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner		7,176$0.00011,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:40 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner		7,176$01,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:38 pm		N/A
N/A		Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner		7,176$0.00011,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:38 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner		7,176$01,226,412
(Indirect)		View

Ownership(A)		2022-11-30
4:37 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		0$07,176
(Indirect)		View

Ownership(A)		2022-11-30
4:36 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner		0$07,176
(Indirect)		View

Ownership(A)		2022-11-30
4:34 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner		0$07,176
(Indirect)		View
2022-07-15
Exercise		2022-07-19
4:40 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		46,034$0103,855
(Direct)		View
2022-07-15
Exercise		2022-07-19
4:40 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		46,034$0.3103,855
(Direct)		View
2022-07-13
Exercise		2022-07-15
4:40 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		1,916$0149,889
(Direct)		View
2022-07-13
Exercise		2022-07-15
4:40 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		1,916$0.3149,889
(Direct)		View
2022-06-14
Exercise		2022-06-14
6:57 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		9,400$0151,805
(Direct)		View
2022-06-14
Exercise		2022-06-14
6:57 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		9,400$0.3151,805
(Direct)		View
2022-06-09
Exercise		2022-06-10
4:12 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		5,000$0257,678
(Direct)		View
2022-06-09
Exercise		2022-06-10
4:12 pm		N/A
N/A		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		5,000$0.3257,678
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:30 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner		8,293$08,293
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:28 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSKnowles Julius
Director		8,293$08,293
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:27 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner		8,293$08,293
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:26 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSGRAY MARY ANN
Director		8,293$08,293
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:25 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSGORDON CARL L
Director		8,293$08,293
(Direct)		View
2022-06-01
Option Award		2022-06-03
4:24 pm		N/A
2032-05-31		Keros Therapeutics Inc.KROSFarzan Nima
Director		8,293$08,293
(Direct)		View
2022-05-11
Exercise		2022-05-13
4:37 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$0151,805
(Direct)		View
2022-05-11
Exercise		2022-05-13
4:37 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$0.3151,805
(Direct)		View
2022-04-11
Exercise		2022-04-13
4:36 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$0157,105
(Direct)		View
2022-04-11
Exercise		2022-04-13
4:36 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		5,300$0.3157,105
(Direct)		View
2022-04-06
Exercise		2022-04-08
4:21 pm		N/A
2030-04-07		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		1,728$08,002
(Direct)		View
2022-04-06
Exercise		2022-04-08
4:21 pm		N/A
N/A		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		1,728$168,002
(Direct)		View
2022-04-04
Exercise		2022-04-06
4:49 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		7,950$0162,405
(Direct)		View
2022-04-04
Exercise		2022-04-06
4:49 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		7,950$0.3162,405
(Direct)		View
2022-04-01
Exercise		2022-04-05
4:31 pm		N/A
2030-04-07		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		864$09,730
(Direct)		View
2022-04-01
Exercise		2022-04-05
4:31 pm		N/A
N/A		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		864$169,730
(Direct)		View
2022-03-11
Exercise		2022-03-15
4:37 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0170,355
(Direct)		View
2022-03-11
Exercise		2022-03-15
4:37 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0.3170,355
(Direct)		View
2022-02-11
Exercise		2022-02-15
4:26 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0173,005
(Direct)		View
2022-02-11
Exercise		2022-02-15
4:26 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0.3173,005
(Direct)		View
2022-02-01
Option Award		2022-02-03
4:45 pm		N/A
2032-01-31		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		100,000$0100,000
(Direct)		View

Ownership		2022-02-03
4:37 pm		N/A
2029-09-18		Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer		0$032,898
(Direct)		View
2022-01-21
Option Award		2022-01-25
4:17 pm		N/A
2032-01-20		Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer		165,000$0165,000
(Direct)		View
2022-01-21
Option Award		2022-01-25
4:15 pm		N/A
2032-01-20		Keros Therapeutics Inc.KROSRegnante Keith
Chief Financial Officer		50,000$050,000
(Direct)		View
2022-01-21
Option Award		2022-01-25
4:14 pm		N/A
2032-01-20		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		50,000$050,000
(Direct)		View
2022-01-21
Option Award		2022-01-25
4:12 pm		N/A
2032-01-20		Keros Therapeutics Inc.KROSCooper Simon Peter
Chief Medical Officer		50,000$050,000
(Direct)		View
2022-01-11
Exercise		2022-01-13
4:39 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0175,655
(Direct)		View
2022-01-11
Exercise		2022-01-13
4:39 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0.3175,655
(Direct)		View
2022-01-05
Exercise		2022-01-07
4:35 pm		N/A
2028-03-25		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0178,305
(Direct)		View
2022-01-05
Exercise		2022-01-07
4:35 pm		N/A
N/A		Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer		2,650$0.3178,305
(Direct)		View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next